Drug tested to ease debilitating joint pain in scleroderma patients
NCT ID NCT01748084
Summary
This study tested whether the drug rituximab could help reduce joint pain and swelling in people with systemic sclerosis (scleroderma) who had active arthritis. It involved 22 participants whose joint symptoms weren't controlled by standard medications. The main goal was to see if this treatment could improve quality of life by easing these painful symptoms.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Cochin Hospital
Paris, 75014, France
Conditions
Explore the condition pages connected to this study.